{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:04:11Z","timestamp":1780596251353,"version":"3.54.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11657-019-0660-8","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T23:02:37Z","timestamp":1576796557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparison of treatment strategies and thresholds for optimizing fracture prevention in Canada: a simulation analysis"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1056-1691","authenticated-orcid":false,"given":"William D.","family":"Leslie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne N.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Lix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Binkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"issue":"10169","key":"660_CR1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","volume":"393","author":"JE Compston","year":"2019","unstructured":"Compston JE, McClung MR, Leslie WD (2019) Osteoporosis. Lancet 393(10169):364\u2013376","journal-title":"Lancet"},{"issue":"10 Suppl","key":"660_CR2","first-page":"S1","volume":"167","author":"JP Brown","year":"2002","unstructured":"Brown JP, Josse RG (2002) Scientific Advisory Council of the Osteoporosis Society of C. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ. 167(10 Suppl):S1\u2013S34","journal-title":"CMAJ."},{"issue":"17","key":"660_CR3","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1503\/cmaj.100771","volume":"182","author":"A Papaioannou","year":"2010","unstructured":"Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD, Scientific Advisory Council of Osteoporosis Canada (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 182(17):1864\u20131873","journal-title":"CMAJ."},{"issue":"8","key":"660_CR4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00198-007-0343-y","volume":"18","author":"JA Kanis","year":"2007","unstructured":"Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18(8):1033\u20131046","journal-title":"Osteoporos Int"},{"key":"660_CR5","unstructured":"Kanis JA (2007) Assessment of osteoporosis at the primary health-care level. Technical Report. Accessible at http:\/\/www.shef.ac.uk\/FRAX\/pdfs\/WHO_Technical_Report.pdf. Published by the University of Sheffield"},{"issue":"3","key":"660_CR6","first-page":"178","volume":"56","author":"K Siminoski","year":"2005","unstructured":"Siminoski K, Leslie WD, Frame H, Hodsman A, Josse RG, Khan A, Lentle BC, L\u00e9vesque J, Lyons DJ, Tarulli G, Brown JP, Canadian Association of Radiologists (2005) Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J 56(3):178\u2013188","journal-title":"Can Assoc Radiol J"},{"issue":"4","key":"660_CR7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00198-007-0550-6","volume":"19","author":"AN Tosteson","year":"2008","unstructured":"Tosteson AN, Melton LJ 3rd, Dawson-Hughes B, Baim S, Favus MJ, Khosla S et al (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19(4):437\u2013447","journal-title":"Osteoporos Int"},{"issue":"1","key":"660_CR8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11657-016-0278-z","volume":"11","author":"JA Kanis","year":"2016","unstructured":"Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV et al (2016) A systematic review of intervention thresholds based on FRAX : a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11(1):25","journal-title":"Arch Osteoporos"},{"issue":"10","key":"660_CR9","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/jbmr.2531","volume":"30","author":"JA Kanis","year":"2015","unstructured":"Kanis JA, McCloskey EV, Harvey NC, Johansson H, Leslie WD (2015) Intervention thresholds and the diagnosis of osteoporosis. J Bone Miner Res 30(10):1747\u20131753","journal-title":"J Bone Miner Res"},{"key":"660_CR10","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1007\/s00198-017-4160-7","volume":"28","author":"H Johansson","year":"2017","unstructured":"Johansson H, Azizieh F, Al Ali N, Alessa T, Harvey NC, McCloskey E et al (2017) FRAX- vs. T-score-based intervention thresholds for osteoporosis. Osteoporos Int 28:3099\u20133105","journal-title":"Osteoporos Int"},{"issue":"8","key":"660_CR11","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s00198-015-3176-0","volume":"26","author":"E McCloskey","year":"2015","unstructured":"McCloskey E, Kanis JA, Johansson H, Harvey N, Oden A, Cooper A et al (2015) FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK. Osteoporos Int 26(8):2091\u20132099","journal-title":"Osteoporos Int"},{"issue":"10","key":"660_CR12","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00198-008-0712-1","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A, National Osteoporosis Guideline Group (2008) Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int 19(10):1395\u20131408","journal-title":"Osteoporos Int"},{"issue":"1","key":"660_CR13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bone.2004.08.018","volume":"36","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Borgstrom F, Zethraeus N, Johnell O, Oden A, Jonsson B (2005) Intervention thresholds for osteoporosis in the UK. Bone. 36(1):22\u201332","journal-title":"Bone."},{"issue":"5","key":"660_CR14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s001980170112","volume":"12","author":"JA Kanis","year":"2001","unstructured":"Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12(5):417\u2013427","journal-title":"Osteoporos Int"},{"key":"660_CR15","unstructured":"National Institute for Health and Care Excellence (NICE) (2017) Bisphosphonates for treating osteoporosis. Technical appraisal guidance TA464"},{"issue":"3","key":"660_CR16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1385\/JCD:6:3:275","volume":"6","author":"WD Leslie","year":"2003","unstructured":"Leslie WD, Metge C (2003) Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom 6(3):275\u2013282","journal-title":"J Clin Densitom"},{"issue":"1","key":"660_CR17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1385\/JCD:8:1:025","volume":"8","author":"WD Leslie","year":"2005","unstructured":"Leslie WD, Caetano PA, Macwilliam LR, Finlayson GS (2005) Construction and validation of a population-based bone densitometry database. J Clin Densitom 8(1):25\u201330","journal-title":"J Clin Densitom"},{"issue":"5","key":"660_CR18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s001980050093","volume":"8","author":"AC Looker","year":"1998","unstructured":"Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP et al (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8(5):468\u2013489","journal-title":"Osteoporos Int"},{"issue":"5","key":"660_CR19","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bone.2009.01.373","volume":"44","author":"JA Kanis","year":"2009","unstructured":"Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E (2009) FRAX and its applications to clinical practice. Bone. 44(5):734\u2013743","journal-title":"Bone."},{"issue":"3","key":"660_CR20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00198-010-1464-2","volume":"22","author":"WD Leslie","year":"2011","unstructured":"Leslie WD, Lix LM, Langsetmo L, Berger C, Goltzman D, Hanley DA, Adachi JD, Johansson H, Oden A, McCloskey E, Kanis JA (2011) Construction of a FRAX(R) model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int 22(3):817\u2013827","journal-title":"Osteoporos Int"},{"key":"660_CR21","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/jbmr.3682","volume":"34","author":"EJ Bisson","year":"2019","unstructured":"Bisson EJ, Finlayson ML, Ekuma O, Marrie RA, Leslie WD (2019) Accuracy of FRAX(R) in people with multiple sclerosis. J Bone Miner Res 34:1095\u20131100","journal-title":"J Bone Miner Res"},{"issue":"8","key":"660_CR22","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/jbmr.3726","volume":"34","author":"WD Leslie","year":"2019","unstructured":"Leslie WD, Morin SN, Lix LM, Niraula S, McCloskey EV, Johansson H, Harvey NC, Kanis JA (2019) Performance of FRAX in women with breast cancer initiating aromatase inhibitor therapy: a registry-based cohort study. J Bone Miner Res 34(8):1428\u20131435","journal-title":"J Bone Miner Res"},{"issue":"1","key":"660_CR23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3899\/jrheum.150312","volume":"43","author":"CA Peschken","year":"2016","unstructured":"Peschken CA, Hitchon CA, Garland A, Bernstein CN, Chen H, Fransoo R et al (2016) A population-based study of intensive care unit admissions in rheumatoid arthritis. J Rheumatol 43(1):26\u201333","journal-title":"J Rheumatol"},{"issue":"9","key":"660_CR24","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/jbmr.2849","volume":"31","author":"S Yang","year":"2016","unstructured":"Yang S, Leslie WD, Yan L, Walld R, Roos LL, Morin SN, Majumdar SR, Lix LM (2016) Objectively verified parental hip fracture is an independent risk factor for fracture: a linkage analysis of 478,792 Parents and 261,705 Offspring. J Bone Miner Res 31(9):1753\u20131759","journal-title":"J Bone Miner Res"},{"issue":"11","key":"660_CR25","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/jbmr.123","volume":"25","author":"WD Leslie","year":"2010","unstructured":"Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA et al (2010) Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Miner Res 25(11):2350\u20132358","journal-title":"J Bone Miner Res"},{"issue":"3","key":"660_CR26","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00198-010-1465-1","volume":"22","author":"LA Fraser","year":"2011","unstructured":"Fraser LA, Langsetmo L, Berger C, Ioannidis G, Goltzman D, Adachi JD, Papaioannou A, Josse R, Kovacs CS, Olszynski WP, Towheed T, Hanley DA, Kaiser SM, Prior J, Jamal S, Kreiger N, Brown JP, Johansson H, Oden A, McCloskey E, Kanis JA, Leslie WD, CaMos Research Group (2011) Fracture prediction and calibration of a Canadian FRAX(R) tool: a population-based report from CaMos. Osteoporos Int 22(3):829\u2013837","journal-title":"Osteoporos Int"},{"issue":"6","key":"660_CR27","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/jbmr.1582","volume":"27","author":"WD Leslie","year":"2012","unstructured":"Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA, Manitoba Bone Density Program (2012) Does osteoporosis therapy invalidate FRAX for fracture prediction? J Bone Miner Res 27(6):1243\u20131251","journal-title":"J Bone Miner Res"},{"key":"660_CR28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/1471-2458-12-301","volume":"12","author":"LM Lix","year":"2012","unstructured":"Lix LM, Azimaee M, Osman BA, Caetano P, Morin S, Metge C et al (2012) Osteoporosis-related fracture case definitions for population-based administrative data. BMC Public Health 12:301","journal-title":"BMC Public Health"},{"issue":"Supp 1","key":"660_CR29","first-page":"S275","volume":"33","author":"R Epp","year":"2018","unstructured":"Epp R, Alhrbi M, Ward L, Leslie WD (2018) Radiological validation of fracture definitions from administrative data. J Bone Miner Res 33(Supp 1):S275","journal-title":"J Bone Miner Res"},{"issue":"4","key":"660_CR30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.maturitas.2013.05.013","volume":"75","author":"J Compston","year":"2013","unstructured":"Compston J, Bowring C, Cooper A, Cooper C, Davies C, Francis R, Kanis JA, Marsh D, McCloskey E, Reid DM, Selby P, National Osteoporosis Guideline Group (2013) Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas. 75(4):392\u2013396","journal-title":"Maturitas."},{"issue":"1","key":"660_CR31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00198-016-3766-5","volume":"28","author":"M Chakhtoura","year":"2017","unstructured":"Chakhtoura M, Leslie WD, McClung M, Cheung AM, Fuleihan GE (2017) The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model. Osteoporos Int 28(1):127\u2013137","journal-title":"Osteoporos Int"},{"issue":"10","key":"660_CR32","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S et al (2014) Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359\u20132381","journal-title":"Osteoporos Int"},{"issue":"10","key":"660_CR33","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1002\/jbmr.446","volume":"26","author":"DC Mackey","year":"2011","unstructured":"Mackey DC, Black DM, Bauer DC, McCloskey EV, Eastell R, Mesenbrink P, Thompson JR, Cummings SR (2011) Effects of antiresorptive treatment on nonvertebral fracture outcomes. J Bone Miner Res 26(10):2411\u20132418","journal-title":"J Bone Miner Res"},{"key":"660_CR34","doi-asserted-by":"crossref","first-page":"i3365","DOI":"10.1136\/bmj.i3365","volume":"353","author":"B Abrahamsen","year":"2016","unstructured":"Abrahamsen B, Eiken P, Prieto-Alhambra D, Eastell R (2016) Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study. BMJ. 353:i3365","journal-title":"BMJ."},{"issue":"6","key":"660_CR35","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bone.2009.02.014","volume":"44","author":"JA Kanis","year":"2009","unstructured":"Kanis JA, Johansson H, Oden A, McCloskey EV (2009) Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX. Bone. 44(6):1049\u20131054","journal-title":"Bone."},{"issue":"5","key":"660_CR36","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00198-008-0786-9","volume":"20","author":"EV McCloskey","year":"2009","unstructured":"McCloskey EV, Johansson H, Oden A, Vasireddy S, Kayan K, Pande K, Jalava T, Kanis JA (2009) Ten-year fracture probability identifies women who will benefit from clodronate therapy--additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int 20(5):811\u2013817","journal-title":"Osteoporos Int"},{"issue":"7","key":"660_CR37","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/jbmr.1606","volume":"27","author":"EV McCloskey","year":"2012","unstructured":"McCloskey EV, Johansson H, Oden A, Austin M, Siris E, Wang A et al (2012) Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX. J Bone Miner Res 27(7):1480\u20131486","journal-title":"J Bone Miner Res"},{"issue":"8","key":"660_CR38","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/jbmr.3439","volume":"33","author":"F Cosman","year":"2018","unstructured":"Cosman F, Crittenden DB, Ferrari S, Lewiecki EM, Jaller-Raad J, Zerbini C, Milmont CE, Meisner PD, Libanati C, Grauer A (2018) Romosozumab FRAME Study: a post hoc analysis of the role of regional background fracture risk on nonvertebral fracture outcome. J Bone Miner Res 33(8):1407\u20131416","journal-title":"J Bone Miner Res"},{"key":"660_CR39","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/jbmr.3411","volume":"33","author":"E McCloskey","year":"2018","unstructured":"McCloskey E, Johansson H, Harvey NC, Shepstone L, Lenaghan E, Fordham R, Harvey I, Howe A, Cooper C, Clarke S, Gittoes N, Heawood A, Holland R, Marshall T, O'Neill TW, Peters TJ, Redmond N, Torgerson D, Kanis JA, the SCOOP Study Team (2018) Management of patients with high baseline hip fracture risk by FRAX reduces hip fractures-a post hoc analysis of the SCOOP Study. J Bone Miner Res 33:1020\u20131026","journal-title":"J Bone Miner Res"},{"issue":"4","key":"660_CR40","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bone.2010.06.009","volume":"47","author":"JA Kanis","year":"2010","unstructured":"Kanis JA, Johansson H, Oden A, McCloskey EV (2010) A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX. Bone. 47(4):729\u2013735","journal-title":"Bone."},{"issue":"8","key":"660_CR41","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/jbmr.1625","volume":"27","author":"MG Donaldson","year":"2012","unstructured":"Donaldson MG, Palermo L, Ensrud KE, Hochberg MC, Schousboe JT, Cummings SR (2012) Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial. J Bone Miner Res 27(8):1804\u20131810","journal-title":"J Bone Miner Res"},{"issue":"8","key":"660_CR42","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/jbmr.3163","volume":"32","author":"EV McCloskey","year":"2017","unstructured":"McCloskey EV, Johansson H, Oden A, Harvey NC, Jiang H, Modin S et al (2017) The Effect of Abaloparatide-SC on fracture risk is independent of baseline FRAX fracture probability: a post hoc analysis of the ACTIVE Study. J Bone Miner Res 32(8):1625\u20131631","journal-title":"J Bone Miner Res"},{"issue":"9","key":"660_CR43","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s00198-015-3129-7","volume":"26","author":"NC Harvey","year":"2015","unstructured":"Harvey NC, Kanis JA, Oden A, Nakamura T, Shiraki M, Sugimoto T et al (2015) Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX. Osteoporos Int 26(9):2347\u20132353","journal-title":"Osteoporos Int"},{"issue":"11","key":"660_CR44","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1007\/s00198-015-3173-3","volume":"26","author":"NC Harvey","year":"2015","unstructured":"Harvey NC, Kanis JA, Oden A, Burge RT, Mitlak BH, Johansson H et al (2015) FRAX and the effect of teriparatide on vertebral and non-vertebral fracture. Osteoporos Int 26(11):2677\u20132684","journal-title":"Osteoporos Int"},{"issue":"8","key":"660_CR45","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s00198-010-1474-0","volume":"22","author":"JA Kanis","year":"2011","unstructured":"Kanis JA, Johansson H, Oden A, McCloskey EV (2011) A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX((R)). Osteoporos Int 22(8):2347\u20132355","journal-title":"Osteoporos Int"},{"issue":"10122","key":"660_CR46","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","volume":"391","author":"L Shepstone","year":"2018","unstructured":"Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, Gittoes N, Harvey I, Harvey N, Heawood A, Holland R, Howe A, Kanis J, Marshall T, O'Neill T, Peters T, Redmond N, Torgerson D, Turner D, McCloskey E, SCOOP Study Team (2018) Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet. 391(10122):741\u2013747","journal-title":"Lancet."},{"issue":"2","key":"660_CR47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/bib\/bbw107","volume":"19","author":"R Blagus","year":"2018","unstructured":"Blagus R, Goeman JJ (2018) What (not) to expect when classifying rare events. Brief Bioinform 19(2):341\u2013349","journal-title":"Brief Bioinform"},{"issue":"8","key":"660_CR48","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/jbmr.3717","volume":"34","author":"CJ Crandall","year":"2019","unstructured":"Crandall CJ, Schousboe JT, Morin SN, Lix LM, Leslie W (2019) Performance of FRAX and FRAX-based treatment thresholds in women aged 40 years and older: The Manitoba BMD Registry. J Bone Miner Res 34(8):1419\u20131427","journal-title":"J Bone Miner Res"},{"issue":"4","key":"660_CR49","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jbmr.3636","volume":"34","author":"CJ Crandall","year":"2019","unstructured":"Crandall CJ, Larson J, Manson JE, Cauley JA, LaCroix AZ, Wactawski-Wende J, Datta M, Sattari M, Schousboe JT, Leslie WD, Ensrud KE (2019) A comparison of US and Canadian osteoporosis screening and treatment strategies in postmenopausal women. J Bone Miner Res 34(4):607\u2013615","journal-title":"J Bone Miner Res"},{"key":"660_CR50","doi-asserted-by":"crossref","unstructured":"Crandall CJ, Larson J, LaCroix A, Cauley JA, LeBoff MS, Li W et al (2019) Predicting fracture risk in younger postmenopausal women: comparison of the Garvan and FRAX risk calculators in the Women's Health Initiative Study. J Gen Intern Med 34(2):235\u2013242","DOI":"10.1007\/s11606-018-4696-z"},{"key":"660_CR51","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00198-019-05106-3","volume":"30","author":"WD Leslie","year":"2019","unstructured":"Leslie WD, Morin SN, Lix LM, Martineau P, Bryanton M, McCloskey EV et al (2019) Fracture prediction from self-reported falls in routine clinical practice: a registry-based cohort study. Osteoporos Int 30:2195\u20132203","journal-title":"Osteoporos Int"},{"key":"660_CR52","doi-asserted-by":"crossref","unstructured":"Harvey NC, Oden A, Orwoll E, Lapidus J, Kwok T, Karlsson MK et al (2018) Falls predict fractures independently of FRAX probability: a meta-analysis of the osteoporotic fractures in Men (MrOS) Study. J Bone Miner Res 33(3):510\u2013516","DOI":"10.1002\/jbmr.3331"},{"issue":"5","key":"660_CR53","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/jbmr.2734","volume":"31","author":"EV McCloskey","year":"2016","unstructured":"McCloskey EV, Oden A, Harvey NC, Leslie WD, Hans D, Johansson H et al (2016) A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res 31(5):940\u2013948","journal-title":"J Bone Miner Res"},{"issue":"3","key":"660_CR54","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jocd.2011.03.007","volume":"14","author":"WD Leslie","year":"2011","unstructured":"Leslie WD, Lix LM (2011) Manitoba bone density P. Effects of FRAX((R)) model calibration on intervention rates: a simulation study. J Clin Densitom 14(3):272\u2013278","journal-title":"J Clin Densitom"},{"issue":"1","key":"660_CR55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00198-009-1127-3","volume":"21","author":"SD Berry","year":"2010","unstructured":"Berry SD, Kiel DP, Donaldson MG, Cummings SR, Kanis JA, Johansson H, Samelson EJ (2010) Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study. Osteoporos Int 21(1):53\u201360","journal-title":"Osteoporos Int"},{"issue":"10","key":"660_CR56","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00198-008-0588-0","volume":"19","author":"ND Nguyen","year":"2008","unstructured":"Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV (2008) Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int 19(10):1431\u20131444","journal-title":"Osteoporos Int"},{"issue":"8","key":"660_CR57","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00198-007-0362-8","volume":"18","author":"ND Nguyen","year":"2007","unstructured":"Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV (2007) Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporos Int 18(8):1109\u20131117","journal-title":"Osteoporos Int"},{"key":"660_CR58","unstructured":"Hippisley-Cox J, Coupland C (2011) Validation of QFracture compared with FRAX: analysis prepared for NICE 2011"},{"key":"660_CR59","doi-asserted-by":"crossref","first-page":"e3427","DOI":"10.1136\/bmj.e3427","volume":"344","author":"J Hippisley-Cox","year":"2012","unstructured":"Hippisley-Cox J, Coupland C (2012) Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study. BMJ. 344:e3427","journal-title":"BMJ."},{"key":"660_CR60","unstructured":"Kahneman D (2011) Thinking, fast and slow. Macmillan"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-019-0660-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11657-019-0660-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-019-0660-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T07:22:19Z","timestamp":1695540139000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11657-019-0660-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["660"],"URL":"https:\/\/doi.org\/10.1007\/s11657-019-0660-8","relation":{},"ISSN":["1862-3522","1862-3514"],"issn-type":[{"value":"1862-3522","type":"print"},{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"assertion":[{"value":"21 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Health Research Ethics Board for the University of Manitoba.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"William Leslie and Lisa Lix: No conflicts of interest.Suzanne Morin: Nothing to declare for the context of this paper, but has received research grants: Amgen.Neil Binkley: Nothing to declare for the context of this paper, but has received research support (paid to institution) from Radius, RTI Health Solutions, GE Healthcare; consultant\/advisory board fees from Amgen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"4"}}